Adalimumab-associated Pulmonary Cryptococcosis
スポンサーリンク
概要
- 論文の詳細を見る
This is the first report of adalimumab-associated pulmonary cryptococcosis. A 56-year-old female with rheumatoid arthritis without a history of pulmonary disease was simultaneously administered adalimumab (40 mg/2 wks), methotrexate (4 mg/wk), and isoniazid (200 mg/day). Five months later, chest radiography revealed a small spiculated pulmonary nodule, and the laboratory test results, including levels of tumor markers and plasma β-D-glucan, were within normal ranges. Since the lesion continued to grow, even after discontinuing adalimumab, it was surgically resected. Grocott staining of the tissue sample revealed black-brown fungi, identified as Cryptococcus neoformans in culture. The patient now remains well, without adalimumab therapy.
論文 | ランダム
- Far-Infrared Absorption by Small Particles of YBa_2Cu_3O_
- 社本修研究 (社本修教授追悼記念論文集)
- 自由貿易協定と東アジアの地域統合を考える
- 地球環境を脅かす利潤第一主義と未来社会への展望 (特集 資本主義の矛盾と地球環境)
- 21世紀の国民の生存と生活の基盤をまもる (特集 日本共産党がめざす21世紀の「日本改革」)